February 17, 2022
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce eget orci imperdiet, fermentum tellus vitae, viverra magna. Ut blandit cursus venenatis. Pellentesque euismod lectus quis bibendum euismod.
February 10, 2022
The Iowa Medical Society (IMS) is conducting a “Midwest Survey of Empathy and Wellbeing in Primary Care Physicians” through the end of February. MMA members are urged to take part.
February 10, 2022
The 2022 Legislature is only in its second week, but already several bills that increase barriers to vaccines have been introduced in St. Paul.
February 3, 2022
The Minnesota Health Leadership Council, a coalition of public and private employers and community organizations, including the MMA, dedicated to improving mental health care and outcomes, has partnered with NORC at the University of Chicago to create a survey to understand individuals’ experiences in accessing healthcare for mental health and substance use conditions. The MMA urges physicians to participate.
February 3, 2022
The Minnesota Department of Human Services (DHS) will host a virtual session on February 10 from 9:30 to 10:30 a.m. to gather stakeholder feedback on a legislatively mandated analysis of the current rate-setting methodology for all outpatient services in Medical Assistance and MinnesotaCare.
February 3, 2022
Health Commissioner Jan Malcolm has approved an advisory committee’s recommendation to add congenital cytomegalovirus (cCMV) to the list of conditions for which Minnesota newborns are routinely screened.
February 3, 2022
The MMA joined more than 330 other healthcare organizations in signing a letter to the leaders of Congress urging them to enact "permanent comprehensive telehealth reform."
February 3, 2022
As of January 1, Medical Assistance and other Minnesota Health Care Programs (MHCP) are now reimbursing for time spent counseling patients on immunizations.
February 3, 2022
Patients registered in Minnesota’s Medical Cannabis Program will be eligible to buy smokable dried cannabis from the state’s medical cannabis dispensaries starting March 1.
February 3, 2022
The MMA’s next noon-time forum will examine sodium-glucose cotransporter-2 (SGLT2) inhibitors, a new 'triple play' for diabetes, cardiovascular and kidney diseases. The forum will take place February 9 from noon to 1 p.m.
